Previous studies have demonstrated that ESCO2 is markedly upregulated in lung, kidney, and colorectal malignancies 11-13; however, no studies have focused on ESCO2 expression in HCC. The gene discussed is ESCO2; the disease is hepatocellular carcinoma.